Abiopharma

Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis

Curaleaf Announces Termination of Equity Purchase Agreement with The Cannabist Company

Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy

Castle Biosciences - Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories

Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2

OKYO Pharma to Ring the Opening Bell at Nasdaq

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Josh Swihart, ECC CEO, Joins Cypherpunk as Strategic Advisor

Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial